Autres langues China SXT Pharmaceuticals, Inc.

Actions

SXTC

VGG2161P1403

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
1,02 ^USD	-3,77 %		-4,67 %	-74,31 %

05/04	China SXT Pharmaceuticals, Inc. publie ses résultats pour le semestre clos le 30 septembre 2023	CI
08/02	Wall Street s'apprête à ouvrir en demi-teinte mercredi ; les demandes d'allocations chômage chutent plus que prévu	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	05/04
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	05/04
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	08/02
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data	08/02
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	02/01
US Equity Futures Set Kick Off 2024 Lower Ahead of Manufacturing PMI, Construction Data	02/01
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule	26/10/23
China SXT Pharmaceuticals to Implement 1-for-25 Reverse Stock Split	04/10/23
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split	04/10/23
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	31/07/23
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	10/05/23
China SXT Pharmaceuticals : Purchase Agreement - Form 6-K	23/03/23
China SXT Pharmaceuticals, Inc. announced that it has received $2 million in funding from Streeterville Capital, LLC	07/03/23
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K	01/03/23
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	25/02/23
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2022	24/02/23
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K	23/12/22
China SXT Pharmaceuticals, Inc. announced that it has received $1.5 million in funding from Streeterville Capital, LLC	20/12/22
China SXT Pharmaceuticals, Inc. announced that it expects to receive $1.5 million in funding from Streeterville Capital, LLC	19/12/22
Top Premarket Gainers	05/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues China SXT Pharmaceuticals, Inc.

Actions

SXTC

VGG2161P1403

Autres langues

Filtres